Role of KRAS mutations in oncogenic activation of intracellular signaling. The human KRAS gene, located on chromosome 12, encodes a small G-protein that functions downstream of EGFRinduced cell signaling. This G-protein belongs to the family of RAS proteins involved in signal transduction pathways that regulate cell development and function. RAS proteins normally cycle between active (RAS-GTP) and inactive (RAS-GDP) conformations. Somatic missense mutations in codon 12 of the KRAS gene, leading to single amino acid substitutions such as p.Gly12Val, are the most common alterations found in colorectal tumors. These KRAS mutations result in RAS proteins that are constitutively in the active RAS-GTP conformation. Unlike wild-type RAS proteins which are deactivated after a short time, the mutated RAS proteins cause continuous activation of RAS signaling pathways in the absence of upstream stimulation of EGFR/HER receptors. This oncogenic activation of RAS signaling pathways leads to abnormal cell growth, proliferation and differentiation 
